-
My Account
In App
My Account
| Particulars | This Scheme | Category |
|---|---|---|
| No. of Stocks | 20 | 76.79 |
| Top 5 Stock Weight | 51.26% | 37.18% |
| Top 10 Stock Weight | 76.58% | 54.15% |
| Top 3 Sector Weight | 99.89% | 34.23% |
| Particulars | This Scheme | Category |
|---|---|---|
| Average mcap (Cr) | 34118.70 | 112668.8 |
| Holdings in large cap stocks | 42.46% | 51.14% |
| Holdings in mid cap stocks | 25.86% | 15.7% |
| Holdings in small cap stocks | 0% | 8.4% |
| Stock Invested in | Sector | Value(Mn) | % of Total Holdings | 1M Change | 1Y Highest Holding | 1Y Lowest Holding | Quantity | 1M Change in Qty |
|---|---|---|---|---|---|---|---|---|
| Sun Pharmaceutical Industries Ltd. | Pharmaceuticals | 18.9 | 17.77% | -0.18% | 22.25% (Oct 2024) | 17.77% (Sep 2025) | 11.85 k | 87.00 |
| Cipla Ltd. | Pharmaceuticals | 9.5 | 8.94% | -0.40% | 9.79% (Feb 2025) | 8.77% (Jun 2025) | 6.33 k | 189.00 |
| Max Healthcare Institute Ltd. | Hospital | 9.3 | 8.76% | -0.20% | 9.81% (Jun 2025) | 8.28% (Nov 2024) | 8.36 k | 251.00 |
| Apollo Hospitals Enterprises Ltd. | Hospital | 8.4 | 7.91% | -0.12% | 8.03% (Aug 2025) | 7.37% (Mar 2025) | 1.14 k | 34.00 |
| Dr. Reddys Laboratories Ltd. | Pharmaceuticals | 8.4 | 7.88% | -0.13% | 9.1% (Dec 2024) | 7.7% (Mar 2025) | 6.85 k | 208.00 |
| Divis Laboratories Ltd. | Pharmaceuticals | 8.1 | 7.65% | -0.48% | 9.11% (May 2025) | 7.65% (Sep 2025) | 1.43 k | 43.00 |
| Fortis Healthcare Ltd. | Hospital | 5.7 | 5.34% | 0.38% | 5.34% (Sep 2025) | 0% (Oct 2024) | 5.86 k | 175.00 |
| Lupin Ltd. | Pharmaceuticals | 5.2 | 4.89% | 0.11% | 6.1% (Dec 2024) | 4.69% (Jul 2025) | 2.72 k | 83.00 |
| Torrent Pharmaceuticals Ltd. | Pharmaceuticals | 4.2 | 3.98% | 0.09% | 3.98% (Sep 2025) | 3.29% (Oct 2024) | 1.18 k | 35.00 |
| Laurus Labs Ltd. | Pharmaceuticals | 3.7 | 3.46% | -0.04% | 3.5% (Aug 2025) | 2.15% (Oct 2024) | 4.37 k | 99.00 |
| Stock Invested in |
Sector |
Sector Total |
Value(Mn) |
% of Total Holdings |
1M Change |
1Y Highest Holding |
1Y Lowest Holding |
Quantity |
1M Change in Qty |
M-Cap |
GroupName |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Sun Pharmaceutical Industries Ltd. | Pharmaceuticals | 76.63 | 18.9 | 17.77% | -0.18% | 22.25% (Oct 2024) | 17.77% (Sep 2025) | 11.85 k | 87.00 | Large Cap | 42.46 |
| Cipla Ltd. | Pharmaceuticals | 76.63 | 9.5 | 8.94% | -0.40% | 9.79% (Feb 2025) | 8.77% (Jun 2025) | 6.33 k | 189.00 | Large Cap | 42.46 |
| Max Healthcare Institute Ltd. | Hospital | 22.01 | 9.3 | 8.76% | -0.20% | 9.81% (Jun 2025) | 8.28% (Nov 2024) | 8.36 k | 251.00 | Other | 31.57 |
| Apollo Hospitals Enterprises Ltd. | Hospital | 22.01 | 8.4 | 7.91% | -0.12% | 8.03% (Aug 2025) | 7.37% (Mar 2025) | 1.14 k | 34.00 | Mid Cap | 25.86 |
| Dr. Reddys Laboratories Ltd. | Pharmaceuticals | 76.63 | 8.4 | 7.88% | -0.13% | 9.1% (Dec 2024) | 7.7% (Mar 2025) | 6.85 k | 208.00 | Other | 31.57 |
| Divis Laboratories Ltd. | Pharmaceuticals | 76.63 | 8.1 | 7.65% | -0.48% | 9.11% (May 2025) | 7.65% (Sep 2025) | 1.43 k | 43.00 | Large Cap | 42.46 |
| Fortis Healthcare Ltd. | Hospital | 22.01 | 5.7 | 5.34% | 0.38% | 5.34% (Sep 2025) | 0% (Oct 2024) | 5.86 k | 175.00 | Other | 31.57 |
| Lupin Ltd. | Pharmaceuticals | 76.63 | 5.2 | 4.89% | 0.11% | 6.1% (Dec 2024) | 4.69% (Jul 2025) | 2.72 k | 83.00 | Large Cap | 42.46 |
| Torrent Pharmaceuticals Ltd. | Pharmaceuticals | 76.63 | 4.2 | 3.98% | 0.09% | 3.98% (Sep 2025) | 3.29% (Oct 2024) | 1.18 k | 35.00 | Mid Cap | 25.86 |
| Laurus Labs Ltd. | Pharmaceuticals | 76.63 | 3.7 | 3.46% | -0.04% | 3.5% (Aug 2025) | 2.15% (Oct 2024) | 4.37 k | 99.00 | Other | 31.57 |
| Alkem Laboratories Ltd. | Pharmaceuticals | 76.63 | 3.4 | 3.23% | 0.25% | 3.36% (Oct 2024) | 2.72% (Jul 2025) | 633.00 | 46.00 | Mid Cap | 25.86 |
| Aurobindo Pharma Ltd. | Pharmaceuticals | 76.63 | 3.4 | 3.21% | 0.21% | 4.35% (Oct 2024) | 3% (Aug 2025) | 3.15 k | 93.00 | Large Cap | 42.46 |
| Glenmark Pharmaceuticals Ltd. | Pharmaceuticals | 76.63 | 3.3 | 3.11% | 0.08% | 3.23% (Jul 2025) | 2.23% (Apr 2025) | 1.69 k | 51.00 | Mid Cap | 25.86 |
| - Mankind Pharma Ltd. | Pharmaceuticals | 76.63 | 3.1 | 2.91% | 0.00% | 3.02% (May 2025) | 0% (Oct 2024) | 1.27 k | 40.00 | Other | 31.57 |
| Zydus Lifesciences Ltd. | Pharmaceuticals | 76.63 | 2.8 | 2.59% | 0.03% | 2.82% (Jan 2025) | 2.38% (Apr 2025) | 2.81 k | 84.00 | Mid Cap | 25.86 |
| Biocon Ltd. | Pharmaceuticals | 76.63 | 2.3 | 2.17% | -0.01% | 2.36% (Jul 2025) | 1.56% (Apr 2025) | 6.76 k | 202.00 | Mid Cap | 25.86 |
| Ipca Laboratories Ltd. | Pharmaceuticals | 76.63 | 2.1 | 1.97% | -0.04% | 2.47% (Dec 2024) | 1.97% (Sep 2025) | 1.56 k | 47.00 | Other | 31.57 |
| Abbott India Ltd. | Pharmaceuticals | 76.63 | 1.7 | 1.62% | -0.10% | 2.01% (Feb 2025) | 1.59% (Jan 2025) | 59.00 | 2.00 | Mid Cap | 25.86 |
| # Piramal Pharma Ltd. | Pharmaceuticals | 76.63 | 1.3 | 1.25% | 1.25% | 1.25% (Sep 2025) | 0% (Oct 2024) | 6.95 k | 6.95 k | Other | 31.57 |
| Syngene International Ltd. | Healthcare research, analytics & technology | 1.25 | 1.3 | 1.25% | 0.01% | 1.93% (Nov 2024) | 1.24% (Aug 2025) | 2.13 k | 65.00 | Mid Cap | 25.86 |
| Stock Invested in | Sector | Value(Mn) | % of Total Holdings | 1M Change | 1Y Highest Holding | 1Y Lowest Holding | Quantity | 1M Change in Qty |
|---|---|---|---|---|---|---|---|---|
| # Piramal Pharma Ltd. | Pharmaceuticals | 1.3 | 1.25% | 1.25% | 1.25% (Sep 2025) | 0% (Oct 2024) | 6.95 k | 6950 |
| Stock Invested in | Sector | Value(Mn) | % of Total Holdings | 1M Change | 1Y Highest Holding | 1Y Lowest Holding | Quantity | 1M Change in Qty |
|---|---|---|---|---|---|---|---|---|
| Granules India Ltd. | Pharmaceuticals | 0.8 | 0.00% | -0.75% | 0.96% (Nov 2024) | 0% (Oct 2024) | 0.00 | -1582 |
| Stock | Sep 2025 | Aug 2025 | Jul 2025 | Jun 2025 | May 2025 | Apr 2025 | Mar 2025 | Feb 2025 | Jan 2025 | Dec 2024 | Nov 2024 | Oct 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sun Pharmaceutical Industries Ltd. | 17.77% | 17.95% | 18.49% | 18.70% | 19.63% | 21.20% | 20.63% | 21.76% | 21.90% | 21.87% | 21.89% | 22.25% | 22.67% |
| Cipla Ltd. | 8.94% | 9.34% | 8.79% | 8.77% | 8.95% | 9.36% | 8.95% | 9.79% | 9.46% | 9.03% | 9.60% | 9.50% | 9.91% |
| Max Healthcare Institute Ltd. | 8.76% | 8.96% | 9.31% | 9.81% | 9.08% | 8.76% | 8.99% | 9.18% | 9.16% | 8.99% | 8.28% | 8.42% | 7.98% |
| Divis Laboratories Ltd. | 7.65% | 8.13% | 8.42% | 8.95% | 9.11% | 8.29% | 8.08% | 8.81% | 8.24% | 8.32% | 8.89% | 8.33% | 7.53% |
| Dr. Reddys Laboratories Ltd. | 7.88% | 8.01% | 7.77% | 8.09% | 8.28% | 7.75% | 7.70% | 8.62% | 8.41% | 9.10% | 8.36% | 8.66% | 8.98% |
| Apollo Hospitals Enterprises Ltd. | 7.91% | 8.03% | 7.62% | 7.57% | 7.54% | 7.56% | 7.37% | 7.75% | 8.02% | 7.93% | 7.84% | 7.92% | 7.94% |
| Lupin Ltd. | 4.89% | 4.78% | 4.69% | 4.85% | 5.13% | 5.43% | 5.40% | 5.81% | 5.83% | 6.10% | 5.63% | 5.87% | 5.75% |
| Fortis Healthcare Ltd. | 5.34% | 4.96% | 4.49% | 4.28% | 3.99% | 3.83% | 3.98% | - | - | - | - | - | - |
| Aurobindo Pharma Ltd. | 3.21% | 3.00% | 3.20% | 3.29% | 3.48% | 3.69% | 3.58% | 3.74% | 3.81% | 4.00% | 4.03% | 4.35% | 4.45% |
| Torrent Pharmaceuticals Ltd. | 3.98% | 3.89% | 3.93% | 3.69% | 3.61% | 3.73% | 3.72% | 3.50% | 3.57% | 3.39% | 3.47% | 3.29% | 3.42% |
| Alkem Laboratories Ltd. | 3.23% | 2.98% | 2.72% | 2.75% | 2.94% | 2.92% | 2.86% | 3.12% | 3.13% | 3.21% | 3.35% | 3.36% | 3.45% |
| Mankind Pharma Ltd. | 2.91% | 2.91% | 2.91% | 2.71% | 3.02% | 2.99% | 2.99% | - | - | - | - | - | - |
| Laurus Labs Ltd. | 3.46% | 3.50% | 3.44% | 2.94% | 2.59% | 2.54% | 2.65% | 2.62% | 2.67% | 2.54% | 2.54% | 2.15% | 1.99% |
| Glenmark Pharmaceuticals Ltd. | 3.11% | 3.03% | 3.23% | 2.73% | 2.38% | 2.23% | 2.56% | 2.44% | 2.76% | 2.60% | 2.63% | 2.84% | 2.75% |
| Zydus Lifesciences Ltd. | 2.59% | 2.56% | 2.43% | 2.56% | 2.52% | 2.38% | 2.44% | 2.77% | 2.82% | 2.61% | 2.75% | 2.79% | 2.91% |
| Name | Type of Instrument | Weight (%) |
|---|---|---|
| TREPS | TREPS | 0.09% |
| Net Receivables | Net Receivables | 0.02% |
Grow Your Money Steadily with 9.45% Fixed Returns 9.45% CAPRI GLOBAL CAPITAL LIMITED 13/Oct/2030 ✔️ Coupon: 9.45% ✔️ Rating: Acuite (SMERA) AA Stable, Infomerics AA Positive ✔️ Tenor: 4y 11m (Maturity: 13/Oct/2030) Senior Secured Bond | NBFC Bond | High Return Bond | Listed Capri Global Capital Limited brings you the perfect blend of safety and attractive 9.45% fixed returns. ???? Explore on The Fixed Income: https://www.thefixedincome.com/product/dVJlbWJnPT0=/945-capri-global-capital-limited-13oct2030?utm_source=Moneycontrol&utm_medium=Forum&utm_campaign=Product_list View more
Posted by : The Fixed Income
Repost this message
Grow Your Money Steadily with 9.45% Fixed Returns 9.45% CAPRI GLOBAL CAPITAL LIMITED 13/Oct/2030 ✔️ Coupon: 9.45% ✔️ Rating: Acuite (SMERA) AA Stable, Infomerics AA Positive ✔️ Tenor: 4y 11m (Maturity: 13/Oct/2030) Senior Secured Bond | NBFC Bond | High Return Bond | Listed Capri Global Capital Limited brings you the perfect blend of safety and attractive 9.45% fixed returns. ???? Explore on The Fixed Income: https://www.thefixedincome.com/product/dVJlbWJnPT0=/945-capri-global-capital-limited-13oct2030?utm_source=Moneycontrol&utm_medium=Forum&utm_campaign=Product_list
need your suggestion for sbi psu fund direct growth stay or switch View more
Posted by : shravanashok
Dividend last declared by SBI Long Term Equity Fund - regular Plan -IDCW was in the year 2022. Is there any specific reason given by fund managers for non declaration of dividend. Please let me know. View more
Posted by : ravisistla
Hello sir, I have been invested in these funds since 2017. Last SIP was in 2021. As their NAV have grown so I was thinking of switching to other funds with lower NAV. View more
Posted by : sunny85deol
